Complimentary viewing of this annual meeting symposium is provided courtesy of Merck. This is NOT for CME credit.

Target Audience:
This program has been designed to meet the educational needs of allergists/immunologists, and other healthcare professionals utilizing allergy immunotherapy strategies in practice 

Learning Objectives:
Upon completion of this session, participants should be able to:

• Recognize the similarities and differences in logistics, efficacy, and safety of SLIT and SCIT for inhalant allergies
• Discuss results of recent food allergy immunotherapy clinical trials
• Discuss likely future strategies for performing immunotherapy, including using adjuvants, biologicals and peptides

Faculty:

Myron Zitt, MD
Mid-Island Allergy Group, Plainview, NY
Consultant/Advisor: Integrity, Sanofi, McNeil, Boehringer Ingelheim; Speaker: Integrity, Mylan, Meda, Boston Scientific

Harold S. Nelson, MD
Professor of Medicine, Department of Medicine, National Jewish Health and University of Colorado Denver School of Medicine, Denver, CO
Consultant/Advisor: AstraZeneca, Circassia, Merck, Pearl Therapeutics; Supported/Contracted Research: Circassia

Kari C. Nadeau, MD
Director of Sean N. Parker Center for Allergy Research, Stanford University, Stanford, CA
No financial relationships to disclose

Stanley M. Fineman, MD, MBA
Adjunct Associate Professor, Department of Pediatrics, Emory University School of Medicine; Atlanta Allergy & Asthma, Atlanta, GA Speaker: AstraZeneca, Genentech, Meda, Merck, Mylan; Supported/Contracted Research: Genentech, Meda

Disclaimer:
The information is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient's medical condition.